A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab

Journal of Clinical Rheumatology

Volumn 16, Issue 4, 2010, Pages 185-187

  Geissal, Erik D ^a   Wernick, Richard ^a  

^a PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

Behcet disease; Infliximab; MAGIC syndrome; Relapsing polychondritis; Scleritis; TNF alpha inhibitors

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CYCLOPHOSPHAMIDE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; HYPERTROPHIC OSTEOARTHROPATHY; LABORATORY TEST; LUNG FUNCTION TEST; MAGIC SYNDROME; MALE; MAXILLA SINUSITIS; MOUTH ULCER; PENILE BIOPSY; PENIS DISEASE; PRIORITY JOURNAL; RELAPSING POLYCHONDRITIS; SYMPTOMATOLOGY; TREATMENT RESPONSE; WEGENER GRANULOMATOSIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; HUMANS; MALE; POLYCHONDRITIS, RELAPSING; REMISSION INDUCTION; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953137510     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181dfce16     Document Type: Article

References (24)

1. Firestein GS, Gruber HE, Weisman MH, et al. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behcet disease. Am J Med. 1985;79:65-72.
2. Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med. 1998;129:114-122.
3. Molina JF, Espinoza LR. Relapsing polychondritis. Baillieres Clin Rheumatol. 2000;14:97-109.
4. McAdam LP, O'Hanlan MA, Bluestone R, et al. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976;55:193-215.
5. Ng CS, Hogan P, McKenzie S, et al. Mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome complicated by aneurysmal aortitis. J Clin Rheumatol. 2007;13:221-223.
6. Caceres M, Estrera AL, Buja LM, et al. Transverse aortic arch replacement associated with MAGIC syndrome: case report and literature review. Ann Vasc Surg. 2006;20:395-398.
7. Gertner E. Severe recurrent neurological disease in the MAGIC syndrome. J Rheumatol. 2004;31:1018-1019.
8. Nanke Y, Kamatani N, Kobashigawa T, et al. Two Japanese cases with MAGIC syndrome (mouth and genital ulcers with inflamed cartilage). Clin Exp Rheumatol. 2006;24 (5 suppl 42) : S113-S114.
9. Kim M, Park K, Min J, et al. A case of polychondritis in a patient with Behcet disease. Korean J Intern Med. 2005;20:339-342.
10. Kotter I, Deuter C, Gunaydin I, et al. MAGIC or not MAGIC-does the MAGIC (mouth and genital ulcers with inflamed cartilage) syndrome really exist? A case report and review of the literature. Clin Exp Rheumatol. 2006;24 (5 suppl 42) : S108-S112.
11. Imai H, Motegi M, Mizuki N, et al. Mouth and genital ulcers with inflamed cartilage (MAGIC syndrome) : a case report and literature review. Am J Med Sci. 1997;314:330-332.
12. Le TD, Wechsler B, Piette JC, et al. Aortic insufficiency and recurrent valve prosthesis dehiscence in MAGIC syndrome. J Rheumatol. 1993;20:397-398.
13. Orme RL, Nordlund JJ, Barich L, et al. The MAGIC syndrome (mouth and genital ulcers with inflamed cartilage). Arch Dermatol. 1990;126:940-944.
14. Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503-508.
15. Cazabon S, Over K, Butcher J. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis. Eye. 2005;19:222-224.
16. Kraus VB, Stabler T, Le E, et al. Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis. Arthritis Rheum. 2003;48:2942-2948.
17. Carter JD. Treatment of relapsing polychondritis with a TNF antagonist. J Rheumatol. 2005;32:1413.
18. Richez C, Dumoulin C, Coutouly X, et al. Successful treatment of relapsing polychondritis with infliximab. Clin Exp Rheumatol. 2004;22:629-631.
19. Mpofu S, Estrach C, Curtis J, et al. Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab. Rheumatology. 2003;42:1117-1118.
20. Saadoun D, Deslandre CJ, Allanore Y, et al. Sustained response to infliximab in 2 patients with refractory relapsing polychondritis. J Rheumatol. 2003;30:1394-1395.
21. Matzies FG, Manger B, Schmitt-Haendle M, et al. Severe septicaemia in a patient with polychondritis and Sweet's syndrome after initiation of treatment with infliximab. Ann Rheum Dis. 2003;62:81-82.
22. Bell D, Wright D, Witt PD. Durability of nasal reconstruction in an adolescent with relapsing polychondritis treated with infliximab. Plast Reconstr Surg. 2007;120:1087-1088.
23. Brust J. Vasculitis owing to substance abuse. Neurol Clin. 1997;15:946-957.
24. Trimarchi M, Gregorini G, Facchetti F, et al. Cocaine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener's granulomatosis. Medicine (Baltimore). 2001;80:391-404.